Investor Stock List
Ranked #7,108 of 8,699 institutional investors

Andera Partners

Paris, I0

$149M
US stock portfolio at live prices · today +$1.5M (+1.01%)
Market closed. Prices as of Nov 20, 6:11 AM ET
Value at quarter end (Q3 2026)
$176M
Change from Q2 2026
−$30.8M (−14.91%)
Positions
5 · 0 new, 1 sold out
Filed
Oct 16, 2026

Not counted in the ranking: none$77.9M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
AVLN 17.9%MLYS 15.1%IVA 8.41%AGMB 5.80%EVMN 0.47%
StockSharesValue, live% of portfoliovs Q2 2026
AVLN Avalyn Pharma Inc.929,824$26.7M17.9%Unchanged
MLYS Mineralys Therapeutics, Inc.1,591,917$22.5M15.1%Unchanged
IVA Inventiva S.A.3,633,181$12.5M8.41%Unchanged
AGMB AgomAb Therapeutics NV1,538,702$8.6M5.80%Unchanged
EVMN Evommune Inc97,362$705K0.47%Reduced −93%

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
ABVX ABIVAX Société Anonyme78,125$6.3M